Catalyst Pharmaceuticals, Inc. (CPRX): Price and Financial Metrics
Catalyst Pharmaceuticals, Inc. (CPRX)
Today's Latest Price: $3.19 USD
Updated Oct 23 4:00pm
Add CPRX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
CPRX Stock Summary
- The ratio of debt to operating expenses for Catalyst Pharmaceuticals Inc is higher than it is for about merely 0.36% of US stocks.
- With a year-over-year growth in debt of -100%, Catalyst Pharmaceuticals Inc's debt growth rate surpasses merely 0% of about US stocks.
- Revenue growth over the past 12 months for Catalyst Pharmaceuticals Inc comes in at 186.6%, a number that bests 96.54% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Catalyst Pharmaceuticals Inc, a group of peers worth examining would be ATEN, LMNX, VIAV, IVAC, and AXTI.
- CPRX's SEC filings can be seen here. And to visit Catalyst Pharmaceuticals Inc's official web site, go to www.catalystpharma.com.
CPRX Stock Price Chart Interactive Chart >
CPRX Price/Volume Stats
| Current price | $3.19 | 52-week high | $5.83 |
| Prev. close | $3.18 | 52-week low | $2.55 |
| Day low | $3.11 | Volume | 947,400 |
| Day high | $3.22 | Avg. volume | 1,950,643 |
| 50-day MA | $3.26 | Dividend yield | N/A |
| 200-day MA | $4.09 | Market Cap | 330.05M |
Catalyst Pharmaceuticals, Inc. (CPRX) Company Bio
Catalyst Pharmaceuticals focuses on the development and commercialization of prescription drugs targeting rare neurological diseases and disorders. The company was founded in 2002 and is based in Coral Gables, Florida.
Loading social stream, please wait...